Market Overview:
The global chenodeoxycholic acid market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for ursodeoxycholic acid synthesis and steroids and steroid derivatives. Chenodeoxycholic acid is used as an intermediate in the synthesis of ursodeoxycholic acid, which is used for the treatment of various liver diseases such as primary biliary cirrhosis, cholestasis, and gallstones. Additionally, chenodeoxycholic acid is also used in the manufacture of steroids and steroid derivatives which are widely used in various applications such as pharmaceuticals, personal care products, agrochemicals etc.
Product Definition:
Chenodeoxycholic acid is a bile acid, one of the primary constituents of bile. It is produced by the liver and helps to digest fats. Chenodeoxycholic acid also helps to remove toxins from the liver and recycle red blood cells.
80-90% Purity:
80-90% purity is a highly concentrated form of cholinc acid, which is used as an intermediate in the production of many chemicals. It can be extracted from any natural source including human urine and bile.
95-98% Purity:
It is an important building block for the synthesis of vitamin D3 which helps in the absorption of calcium and phosphorous in the body. Vitamin D3 plays an important role in helping to reduce blood pressure, prevent diabetes, and ensure normal bone health.
Application Insights:
The use of chenodeoxycholic acid for the synthesis of ursodeoxycholic acid is majorly observed in China and India. The application of chenodeoxycholic acid in the production of steroids and steroid derivatives such as prednisone, methylprednisolone, hydrocortisone, corticosterone and aldosterone is also significant globally. In addition to this, it has been used for various other applications such as pharmaceutical intermediates production (steroids hormones), research on cholesterol metabolism (chenodeoxycholic acid) and its potential use against cancer cells (actinic keratosis).
In terms of revenue, ursodeoxyoctanoate/URSO dominated the global market with a share that stood at over 35% in 2017.
Regional Analysis:
Asia Pacific dominated the global market in 2017. The region is expected to maintain its position throughout the forecast period owing to increasing awareness regarding chenodeoxycholic acid usage and presence of a large target population. Moreover, China is one of the largest producers of chenodeoxycholic acid which makes it an ideal place for manufacturers to set up their production facilities.
The pharmaceutical industry in Europe has witnessed exponential growth over the past few years on account of rising R&D investments by leading pharmaceutical companies coupled with government support for innovation and development of new medicines. This, in turn, has led to increased demand for cholestatic products such as chenodeoxycholic acid across various regions including Europe and Asia Pacific thus fueling market growth across these regions as well.
Growth Factors:
- Increasing prevalence of obesity and metabolic syndrome
- Rising geriatric population
- Growing demand for minimally invasive surgeries
- Technological advancements in the field of cholic acid therapy
- increasing research and development investments
Scope Of The Report
Report Attributes
Report Details
Report Title
Chenodeoxycholic Acid Market Research Report
By Type
80-90% Purity, 95-98% Purity
By Application
Ursodeoxycholic Acid Synthesis, Steroids and Steroid Derivatives
By Companies
ICE Group, Zhongshan Belling Biotechnology, PharmaZell GmbH, Suzhou Tianlu Bio-pharmaceutical, Daewoong, Linyi Tianli Biochemical, Changde Yungang Biotechnology, Guanghan Yikang Biological, Tianjin NWS Biotechnology and Medicine, Shandong Zhongjing Biological
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
218
Number of Tables & Figures
153
Customization Available
Yes, the report can be customized as per your need.
Global Chenodeoxycholic Acid Market Report Segments:
The global Chenodeoxycholic Acid market is segmented on the basis of:
Types
80-90% Purity, 95-98% Purity
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Ursodeoxycholic Acid Synthesis, Steroids and Steroid Derivatives
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ICE Group
- Zhongshan Belling Biotechnology
- PharmaZell GmbH
- Suzhou Tianlu Bio-pharmaceutical
- Daewoong
- Linyi Tianli Biochemical
- Changde Yungang Biotechnology
- Guanghan Yikang Biological
- Tianjin NWS Biotechnology and Medicine
- Shandong Zhongjing Biological
Highlights of The Chenodeoxycholic Acid Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 80-90% Purity
- 95-98% Purity
- By Application:
- Ursodeoxycholic Acid Synthesis
- Steroids and Steroid Derivatives
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Chenodeoxycholic Acid Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Chenodeoxycholic acid is a molecule found in the bile of mammals. It is synthesized from cholesterol and has been shown to have anti-inflammatory properties.
Some of the major players in the chenodeoxycholic acid market are ICE Group, Zhongshan Belling Biotechnology, PharmaZell GmbH, Suzhou Tianlu Bio-pharmaceutical, Daewoong, Linyi Tianli Biochemical, Changde Yungang Biotechnology, Guanghan Yikang Biological, Tianjin NWS Biotechnology and Medicine, Shandong Zhongjing Biological.
The chenodeoxycholic acid market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Chenodeoxycholic Acid Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Chenodeoxycholic Acid Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Chenodeoxycholic Acid Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Chenodeoxycholic Acid Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Chenodeoxycholic Acid Market Size & Forecast, 2020-2028
4.5.1 Chenodeoxycholic Acid Market Size and Y-o-Y Growth
4.5.2 Chenodeoxycholic Acid Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 80-90% Purity
5.2.2 95-98% Purity
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Ursodeoxycholic Acid Synthesis
6.2.2 Steroids and Steroid Derivatives
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Chenodeoxycholic Acid Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Chenodeoxycholic Acid Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 80-90% Purity
9.6.2 95-98% Purity
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Ursodeoxycholic Acid Synthesis
9.10.2 Steroids and Steroid Derivatives
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 80-90% Purity
10.6.2 95-98% Purity
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Ursodeoxycholic Acid Synthesis
10.10.2 Steroids and Steroid Derivatives
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 80-90% Purity
11.6.2 95-98% Purity
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Ursodeoxycholic Acid Synthesis
11.10.2 Steroids and Steroid Derivatives
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 80-90% Purity
12.6.2 95-98% Purity
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Ursodeoxycholic Acid Synthesis
12.10.2 Steroids and Steroid Derivatives
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 80-90% Purity
13.6.2 95-98% Purity
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Ursodeoxycholic Acid Synthesis
13.10.2 Steroids and Steroid Derivatives
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Chenodeoxycholic Acid Market: Competitive Dashboard
14.2 Global Chenodeoxycholic Acid Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 ICE Group
14.3.2 Zhongshan Belling Biotechnology
14.3.3 PharmaZell GmbH
14.3.4 Suzhou Tianlu Bio-pharmaceutical
14.3.5 Daewoong
14.3.6 Linyi Tianli Biochemical
14.3.7 Changde Yungang Biotechnology
14.3.8 Guanghan Yikang Biological
14.3.9 Tianjin NWS Biotechnology and Medicine
14.3.10 Shandong Zhongjing Biological
